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Activation of the Gal1 Gene of Yeast
by Pairs of ‘Non-Classical’ Activators
suffices to trigger gene activation [6, 7]. TFIID, a third
complex required for activation of certain genes in yeast,
is not required for activation of the GAL1 gene [17–19].
Jason X. Cheng, Michele Gandolfi,
and Mark Ptashne*
Molecular Biology Program
Sloan-Kettering Institute Here we analyze fusion proteins comprising a DNA
binding domain attached to one or another componentNew York, NY 10021
of SAGA, mediator, or TFIID. We find that none of these,
binding on its own upstream of a chromosomally inte-
grated reporter, activates transcription significantly.Summary
(Fusion proteins bearing Gal11 [alias Med15] are excep-
tions to this rule as previously described [20–21], a mat-Eukaryotic transcriptional activators work by recruit-
ter we return to in the Discussion.) When tethered toing to DNA the transcriptional machinery, including
adjacent sites on DNA, however, in several cases Media-protein complexes required for chromatin modifica-
tor and SAGA fusion proteins working together activatetion, transcription initiation, and elongation [1, 2].
transcription. We also describe tripartite fusion proteinsWhich of these complexes must be directly recruited
bearing a DNA binding domain, a SAGA component,to trigger transcription? We test various “non-classi-
and a Mediator component that activate transcription.cal” transcription activators (comprising a component
We fused the following proteins, found in SAGA, toof the transcriptional machinery fused to a DNA bind-
the LexA DNA binding domain (DBD) and, separately,ing domain) for their abilities to activate transcription
to the Zif [18] DNA binding domain: Spt20, Spt3, Spt8,of a chromosomally integrated reporter in yeast.
Gcn5, and Ahc1. We created a similar set of fusions toAmong these newly constructed fusion proteins, none
LexA and Zif by using the following proteins found inefficiently activated transcription when working on its
Mediator: Med1, Med2, Med4, Med6, Med12, Med17,own. However, in several instances transcription was
Med20, Med21, and CDK8 (Srb10). Taf1 and Taf14 areactivated by a pair of such fusion proteins tethered to
found in the TFIID complex, and Taf9 and Taf10 areadjacent sites on DNA. In each of these cases, one
present in both SAGA and TFIID [22]. All of these proteinsfusion protein bore a component of the SAGA complex,
were fused to LexA and/or to Zif as well.and the other bore a component of the Mediator com-
We tested the ability of each of these fusion proteins,plex. Transcription was also activated by certain tri-
alone or in combination with another, to activate tran-partite fusion proteins comprising a Mediator and a
scription from an integrated reporter bearing a GAL1 orSAGA component fused to a DNA binding domain.
CYC1 promoter with Zif and LexA sites just upstream.The results are consistent with the finding [3] that the
Figure 1 shows a typical example: the “Mediator fusion”classical activator Gal4, working at the GAL1 pro-
LexA-Med20 and the “SAGA fusion” Zif-Spt20, workingmoter, activates transcription by (at least in part) inde-
together, elicited a much higher level of transcriptionpendently recruiting SAGA and Mediator.
than did either fusion protein working alone. Increasing
the number of LexA sites, or the number of Zif sites,
Results and Discussion resulted in no increase in the activity of either LexA-
Med20 or Zif-Spt20 working alone (not shown). The level
Gal 4, working at the GAL1 promoter, triggers formation of transcription elicited by the combined effect of the
of a transcription complex that contains more than 50 two activators was about 40% of that elicited by Zif-
proteins. This complex is built from several cellular sub- Gal4 working from two Zif sites on the reporter.
complexes, including SAGA (17 proteins), Mediator (24 As shown in Table 1, results similar to those shown
proteins), RNA polymerase (12 proteins), and several in lanes 2 and 3 of Figure 1 were found for each of the
additional general transcription factors (TBP, etc.) [4, 5]. additional fusion proteins described above when they
Bryant et al. [3] described the following series of events worked separately. That is, only a low level of transcrip-
at the GAL1 promoter upon induction: Gal4 first recruited tion was elicited by any of these fusion proteins working
(among the factors studied) SAGA, then Mediator, and on its own. The difference between the virtual inactivity
finally polymerase and several other proteins including of fusion proteins bearing Taf1 and Taf14, on the one
TBP, TFIIB, and TFIIE. In a cell depleted of SAGA, Media- hand, and the low but detectable activity of fusion pro-
tor was recruited, but transcription was not elicited, ap- teins bearingTaf9 and Taf10, on the other, might be
parently because, in the absence of SAGA, polymerase significant: the former two proteins are found only in
and certain other required proteins do not bind the pro- TFIID, a complex not required for transcription of GAL1,
moter [3]. The results are consistent with the suggestion whereas the latter two proteins are also part of SAGA.
that Gal4 touches, and directly recruits, two protein This hint that recruitment of SAGA alone can elicit some
complexes—SAGA and Mediator. Others have also ar- transcription is consistent with the low but detectable
gued that Gal4 directly recruits SAGA [6–12], still others activity of fusions bearing the SAGA component Spt20.
have argued for recruitment of Mediator [13–16], and Table 2 describes some 36 pairwise combinations of
one group has suggested that SAGA recruitment alone fusion proteins tested as in lane 4 of Figure 1. In eight
cases (one of which is shown in Figure 1), a Mediator-
SAGA combination worked synergistically to elicit a level*Correspondence: m-ptashne@ski.mskcc.org
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Table 1. Activities of Non-Classical Activators Comprising a
DNA Binding Domain Fused to a Single Component of the
Transcriptional Machinery
lexA Fusions Activities Zif Fusions Activities
LexA 0.9  0.4 Zif 2.5  2.0
Med1 3.0  1.0 Med1 7.0  2.0
Med2 39.0  9.0 Med2 49.0  8.0
Med4 7.0  2.0 Med4 13.0  3.0
Med6 4.0  1.0 Med6 9.0  1.0
Med12 0.5  0.3 Med12 3.0  0.3
Med15 1230.0  93.0 Med15 450.0  30.0
Med17 3.0  1.0 Med17 17.0  4.0
Med20 15.0  3.0 Med20 15.0  3.0
Med21 0.5  0.5 Med21 3.0  1.0
CDK8 8.0  2.0 CDK8 5.0  1.5
Spt20 29.0  3.0 Spt20 27.0  5.0
Spt3 7.0  1.0 Spt3 6.0  2.0
Spt8 8.0  0.5 Spt8 9.0  0.5
Ahc1 5.0  1.0 Gcn5 3.0  1.0
Tra1 30.0  7.0 Tra1 17.0  1.0
Taf1 3.0  2.0 Taf1 3.0  1.5
Taf30 1.0  0.3 Taf30 3.0  1.3
Taf9 18.0  3.0 Taf9 17.0  4.0
Taf10 23.0  4.0 Taf10 27.0  5.0
Cells bearing the reporter of Figure 1 were transformed with a plas-
mid expressing one or another of these fusion proteins, grown over-
night, and assayed for -galactosidase activity.
Figure 1. Transcription Elicited by Two Non-Classical Activators
Working Separately and Together relative to that of Zif-Gal4 (not shown). Another differ-
The chromosomally integrated reporter bears two Zif sites (and ence between Zif-Gal4 and this tripartite fusion protein
hence binds two Zif monomers) and two LexA sites (and hence is that increasing the number of Zif sites from two to fourbinds two LexA dimers). Cells were transformed with plasmids ex-
enabled Zif-Gal4 to work 4- to 5-fold more efficiently,pressing the indicated fusion proteins (a single plasmid for the first
whereas the activity of the tripartite protein increasedthree lanes, two plasmids for the fourth), grown overnight, and as-
sayed for -galactosidase. The Lex sites were separated from the less than 2-fold (not shown). In this regard the behavior
Zif sites by three base pairs, and similar results were observed when of Zif-Gal4 mimics that of Gal4 itself; increasing the
that separation was increased to 15 base pairs (not shown). number of Gal4 sites is well known to increase activation
elicited by Gal4. Very little transcription was elicited by
Zif-Gal4, and virtually none was elicited by the tripartiteof transcription significantly higher than the sum of that
elicited by the two fusion proteins working separately. protein, as assessed with a reporter bearing a single Zif
site (which binds a Zif monomer) (not shown). The pro-These cases are listed in the last four lines of Table 2. In
no case did pairs of fusion proteins bearing components tein Zif-Med20-Spt20 worked about twice as efficiently
as did Zif-Spt20-Med20 (not shown).from the same complex (SAGA, Mediator, or TFIID) acti-
vate significantly more efficiently than either of the pro- As shown in Table 3, three additional triple fusion
proteins bearing Zif domains (see lines 6–8) workedteins working on its own.
We considered the possibility that the efficiency with about a third as well as did the one shown in the figure
and on line five of the Table. In each case, the constructwhich pairs of Mediator-SAGA fusions (such as that of
Figure 1) work might be affected by steric constraints included a Mediator and a SAGA component, and in no
case did a tripartite protein bearing two proteins fromimposed by the disposition of binding sites on the re-
porter. In the experiment in Figure 1, for example, the the same complex (plus a DBD) work significantly. Table
3 also shows that in two cases the Zif DBD was success-LexA sites are upstream of the Zif sites and therefore
are farther away from the promoter. We therefore con- fully replaced by a LexA DBD in constructing a tripartite
activator.structed a series of triple-fusion proteins, each of which
bears a DBD and two additional proteins. In some cases A simple scenario for the activity of non-classical acti-
vators assumes that any given fusion protein inserts intothose additional proteins were both from a single com-
plex (SAGA, Mediator, or TFIID), and in other cases they the corresponding complex and that this complex is
recruited to the promoter as the DNA binding domainwere from two different complexes (e.g., SAGA and Me-
diator). attaches to DNA. Consistent with the first part of this
idea, we found that the tripartite protein Zif-Med20-Figure 2 shows the activity of a tripartite protein bear-
ing a DBD (Zif), a Mediator component (Med20), and a Spt20 complemented the growth defect (in galactose
medium) imposed by deletion of Spt20 (not shown). Evi-SAGA component (Spt20). This protein, bound to a pair
of Zif sites, activated transcription about as efficiently dently (see reference [18]), despite the attached extra
baggage (i.e., Zif and Med20), the Spt20 protein insertsas did Zif-Gal4 bound to the same sites in a separate
experiment. When these Zif sites were moved farther itself into SAGA, where it works as well as the wild-type,
unencumbered, protein. We do not have any furtherupstream, the activity of the fusion protein decreased
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Table 2. Activities of Pairs of Non-Classical Activators Bound to Adjacent Sites on the Reporter of Figure 1
LexA  Zif Activities LexA  Zif Activities
Mediator  Mediator Med20  Med1 11.0  3.0 Med1  Med17 5.0  2.0
Med20  Med4 4.0  2.0 Med4  Med17 3.0  1.0
Med20  Med6 3.0  0 Med6  Med17 7.0  1.5
Med20  Med12 1.0  0.9 Med12  Med17 1.0  0.5
Med20  Med17 7.0  2.0 Med17  Med17 3.0  0.5
Med20  Med21 1.0  0.3 Med21  Med17 1.0  0.5
Med20  Med22 8.0  1.0 Med22  Med17 13.0  3.5
SAGA  SAGA Gcn5  Spt3 7.0  2.0 Spt20  Gcn5 13.0  5.0
Spt3  Spt20 31.0  4.0 Spt20  Spt3 23.0  5.0
Ahc1  Spt3 4.0  2.0 Spt20  Ahc1 17.0  3.0
TAFs Taf1  Taf1 3.0  1.0 Taf14  Taf1 3.0  0.5
Taf9  Taf1 13.0  4.0 Taf10  Taf1 9.0  4.5
Mediator  TFIID Med20  Taf1 5.0  2.3 Taf1  Med17 11.0  4.5
Med20  Taf14 3.0  1.0 Taf14  Med17 3.0  0.5
Mediator  SAGA Med20  Taf9 119.0  13.0 Taf9  Med17 109.0  15.0
Med20  Taf10 124.0  23.0 Taf10  Med17 119.0  23.0
Med20  Spt20 188.0  33.0 Spt20  Med17 137.0  35.0
Med20  Spt3 89.0  15.0 Spt3  Med17 97.0  25.0
The experiments were performed as described in Table 1, except that the cells bore two plasmids, each expressing one or another of the
fusion proteins.
evidence that complete Mediator or SAGA complexes are nents of SAGA and of the Mediator in vitro (see refer-
ences [9, 11, 12, 14–16], for example), and interactionsrecruited to DNA in our experiments. We imagine that in
the experiments with the tripartite activators, one com- between Gal4 and SAGA have been detected in vivo [6].
It is possible that Gal4 interacts with additional compo-plex (e.g., Mediator), or some subcomponent thereof, is
recruited by one activator, and the other complex is nents of the machinery and that those interactions might
further facilitate activation. For a report of synergisticrecruited by an identical activator bound to an adjacent
Zif site. This would explain the finding that Zif-Med20- activation, by a pair of fusion proteins, of a reporter
bearing a mutant promoter, see reference [23].Spt20 was inactive if the promoter bore only a single
Zif site. In our current experiments, as we have emphasized,
we used reporters that were integrated into the chromo-Our results reinforce the idea [3] that independent
recruitment of two complexes—SAGA and Mediator—to some. We and others [24–27] have found that the re-
quirements for activation by fusion proteins such as thea TATA-containing promoter embedded in the yeast
chromosome facilitates activation of transcription. That ones described here are relaxed when the reporter is
carried on a plasmid. For example, a typical Mediatorproposed dual recruitment may be effected directly by
natural activators such as Gal4. Gal4 contacts compo- component-DBD fusion protein works quite well on its
Figure 2. Transcription Elicited by Two Non-
Classical Activators Working Separately and
Together as Parts of a Tripartite Protein




Table 3. Activities of Tripartite Non-Classical Activators Working on the Promoter of Figure 2
Tripartite Fusions Activities
DBD-Mediator-Mediator Zif-Med20-Med17 0.7  0.4
Zif-Med20-CDK8 7.0  3.0
DBD-SAGA-SAGA Zif-Spt20-Spt3 4.0  2.0
Zif-Spt3-Spt20 17.0  3.0
DBD-Mediator-SAGA Zif-Med20-Spt20 350.0  33.0
Zif-Med20-Spt3 103.0  15.0
Zif-Med20-Taf9 97.0  9.0
Zif-Med20-Taf10 87.0  13.0
DBD-Mediator-TFIID Zif-Med20-Taf1 7.0  2.0
Zif-Med20-Taf14 1.0  1.0
DBD-Mediator-SAGA LexA-Med20-Spt20 203.0  23.0
LexA-Med20-Spt3 83.0  13.0
DBD-Mediator-Mediator LexA-Med20-Med1 3.0  3.0
LexA-Med20-Med6 1.5  0.5
Procedures were as described for the experiments of Table 1.
domains in our experiments: LexA and Zif. Whereas each LexA siteown when the template is carried on a plasmid [27] but
binds a LexA dimer, each Zif site binds a Zif monomer. Zif containsnot (as we show here) when integrated into the chromo-
four zinc fingers, and each monomer binds DNA very tightly, somesome. We do not know whether copy number, chromatin
20-fold more tightly than does a LexA dimer (J.X.C., unpublished
wrapping, or some other difference between integrated data). Activators bearing the Zif DNA binding domain [18, 24] bore,
reporters and those on plasmids might account for their at their N- or C- termini, either Gal4 (147-881) or the full-length Spt20,
Spt3, Spt7, Gcn5, Ahc1, Tra1, Taf1, Taf9, Taf10, and Taf14. A similardifferent responses.
set of fusions was created with the following proteins found only inThe mechanism of activation we have discussed here—
Mediator: Med1, Med2, Med4, Med 6, Med12, Med17, Med20, Med21,independent recruitment of two complexes—evidently
and CDK8 (Srb10). The various LexA fusions have been describedfails to account for the behavior of certain experiments
elsewhere [25]. We constructed the tripartite fusion proteins Zif-
involving the protein Gal11/Med15. This protein is be- Med20-Spt20, Zif-Med20-Spt3, Zif-Med20-Med17, Zif-Med20-Med21,
lieved to be a component only of the Mediator, and yet Zif-Med20-CDK8, Zif-Med20-Taf9, Zif-Med20-Taf10, LexA-Med20-
Spt20, and LexA-Med20-Spt3 by fusing the Zif or LexA DBD andDBD-Med15 fusions (or a single contact between a DNA-
the full lengths of two respective subunits together. They all beartethered protein and Med15) activate transcription of
the Zif or LexA DBD on their N termini.integrated reporters to high levels [20–21]. Preliminary
To construct the reporter plasmids, we inserted two copies of theexperiments (Wu, X., Ogirala, A., and M.P., unpublished)
4-zif binding site and/or lexA sites at 25 bp upstream of the TATA
suggest that, compared with Gal4, a DBD-Med15 pro- box of the GAL1 or CYC1 promoter. We performed assays by grow-
tein requires a longer period of time to establish the high ing cells in synthetic dropout growth media containing 2% galactose
and 2% raffinose at 30C to an OD of 0.8 to 1.0, harvested, andrate of transcription finally elicited by the two activators.
assayed for -galactosidase activity as described previously [25].Perhaps the efficient independent recruitment of SAGA
by Gal4 helps it to work more quickly.
AcknowledgmentsYet another puzzle remains: why do fusions to Med15
work so much better (as assayed after long periods of
We thank Chris Heid and Laura Emerson for technical assistance,activation) than do fusions to other mediator compo-
Monique Floer, Gene Bryant, Xiaoyang Wu, Zhen Lu, and Alex Gannnents? Twice Med15 has been found to be the sole
for discussions, and Steve Hahn for communicating unpublished
target of novel activating peptides [20–21] (a property results. This work is supported by a National Institutes of Health
shared with no other protein in the transcription machin- grant (GM32308) to M.P., Ludwig Professor of Molecular Biology.
ery), and it is believed to be an important target of natural
activating regions as well [15–16], Reeves and Hahn, Received: June 18, 2004
personal communication). Perhaps Med15 is positioned Revised: August 9, 2004
in the mediator such that, when brought to DNA, it pre- Accepted: August 9, 2004
Published: September 21, 2004sents the Mediator in an optimal orientation for interac-
tion with DNA and/or with other components required
for transcription. Consistent with this idea is the finding References
that, among the fusion proteins examined here, DBD-
1. Ptashne, M., and Gann, A. (1997). Transcriptional activitationMed2 was the most active when it was working on its
by recruitment. Nature 386, 569–577.own (Table 1), and DBD-Med3 and DBD-Med16 behaved
2. Ptashne, M., and Gann, A. 2002 Genes and Signals. Cold Spring
similarly (not shown). All three of these Mediator compo- Harbor, New York: Cold Spring Harbor Laboratory Press).
nents—Med2, Med3, and Med16—are part of the Media- 3. Bryant, G.O., and Ptashne, M. (2003). Independent recruitment
tor subdomain (called the “tail” domain) that also con- in vivo by Gal4 of two complexes required for transcription. Mol.
Cell 11, 1301–1309.tains Med15 [28–29].
4. Malik, S., and Roeder, R.G. (2000). Transcriptional regulation
through Mediator-like coactivators in yeast and metazoan cells.Experimental Procedures
Trends Biochem. Sci. 25, 277–283.
5. Hahn, S. (2004). Structure and mechanism of the RNA polymeraseYeast Strains, Plasmids, and Transcription Assay
II transcription machinery. Nat. Struct. Mol. Biol. 11, 394–403.Wild-type FY1301 (MATura3-52, arg4-12, trp1- D63, leu2D1, lys2-
173R2) was kindly provided by F. Winston. We used two DNA binding 6. Bhaumik, S.R., Raha, T., Aiello, D.P., and Green, M.R. (2004).
Gene Activation by Pairs of Fusion Proteins
1679
In vivo target of a transcriptional activator revealed by fluores- differential subunit modifications. J. Biol. Chem. 278, 3831–
3839.cence resonance energy transfer. Genes Dev. 18, 333–343.
7. Bhaumik, S.R., and Green, M.R. (2001). SAGA is an essential 28. Zhang, F., Sumibcay, L., Hinnebusch, A.G., and Swanson, M.
(2004). A triad of subunits from the Gal11/tail domain of Srbin vivo target of the yeast acidic activator Gal4p. Genes Dev.
15, 1935–1945. mediator is an in vivo target of transcriptional activator Gcn4p.
Mol. Cell. Biol. 24, 6871–6886.8. Larschan, E., and Winston, F. (2001). The S. cerevisiae SAGA
complex functions in vivo as a coactivator for transcriptional 29. Dotson, M.R., Yuan, C.X., Roeder, R.G., Myers, L.C., Gustafs-
son, C.M., Jiang, Y.W., Li, Y., Kornberg, R.D., and Asturias,activation by Gal4. Genes Dev. 15, 1946–1956.
9. Carrozza, M.J., John, S., Sil, A.K., Hopper, J.E., and Workman, F.J. (2000). Structural organization of yeast and mammalian
mediator complexes. Proc. Natl. Acad. Sci. USA 97, 14307–J.L. (2002). Gal80 confers specificity on HAT complex interac-
tions with activators. J. Biol. Chem. 277, 24648–24652. 14310.
10. Brown, C.E., Howe, L., Sousa, K., Alley, S.C., Carrozza, M.J.,
Tan, S., and Workman, J.L. (2001). Recruitment of HAT com-
plexes by direct activator interactions with the ATM-related Tra1
subunit. Science 292, 2333–2337.
11. Warfield, L., Ranish, J.A., and Hahn, S. (2004). Positive and
negative functions of the SAGA complex mediated through in-
teraction of Spt8 with TBP and the N-terminal domain of TFIIA.
Genes Dev. 18, 1022–1034.
12. Hall, D.B., and Struhl, K. (2002). The VP16 activation domain
interacts with multiple transcriptional components as deter-
mined by protein-protein cross-linking in vivo. J. Biol. Chem.
277, 46043–46050.
13. Kuras, L., Borggrefe, T., and Kornberg, R.D. (2003). Association
of the Mediator complex with enhancers of active genes. Proc.
Natl. Acad. Sci. USA 100, 13887–13891.
14. Koh, S.S., Ansari, A.Z., Ptashne, M., and Young, R.A. (1998). An
activator target in the RNA polymerase II holoenzyme. Mol. Cell
1, 895–904.
15. Park, J.M., Kim, H.S., Han, S.J., Hwang, M.S., Lee, Y.C., and
Kim, Y.J. (2000). In vivo requirement of activator-specific binding
targets of mediator. Mol. Cell. Biol. 20, 8709–8719.
16. Jeong, C.J., Yang, S.H., Xie, Y., Zhang, L., Johnston, S.A., and
Kodadek, T. (2001). Evidence that Gal11 protein is a target of
the Gal4 activationdomain in the mediator. Biochemistry 40,
9421–9427.
17. Shen, W.C., and Green, M.R. (1997). Yeast TAF(II)145 functions
as a core promoter selectivity factor, not a general coactivator.
Cell 90, 615–624.
18. Cheng, J.X., Floer, M., Ononaji, P., Bryant, G., and Ptashne,
M. (2002). Responses of four yeast genes to changes in the
transcriptional machinery are determined by their promoters.
Curr. Biol. 12, 1828–1832.
19. Basehoar, A.D., Zanton, S.J., and Pugh, B.F. (2004). Identifica-
tion and distinct regulation of yeast TATA box containing genes.
Cell 116, 699–709.
20. Barberis, A., Pearlberg, J., Simkovich, N., Farrell, S., Reinagel,
P., Bamdad, C., Sigal, G., and Ptashne, M. (1995). Contact with
a component of the polymerase II holoenzyme suffices for gene
activation. Cell 81, 359–368.
21. Lu, Z., Ansari, A.Z., Lu, X., Ogirala, A., and Ptashne, M. (2002).
A target essential for the activity of a nonacidic yeast transcrip-
tional activator. Proc. Natl. Acad. Sci. USA 99, 8591–8596.
22. Struhl, K., and Moqtaderi, Z. (1988). The TAFs in the HAT. Cell
94, 1–4.
23. Gonzalez-Couto, E., Klages, N., and Strubin, M. (1997). Syner-
gistic and promoter-selective activation of transcription by re-
cruitment of transcription factors TFIID and TFIIB. Proc. Natl.
Acad. Sci. USA 94, 8036–8041.
24. Cheng, J.X., Nevado, J., Lu, Z., and Ptashne, M. (2002). The TBP-
inhibitory domain of TAF145 limits the effects of non-classical
transcriptional activators. Curr. Biol. 12, 934–937.
25. Gaudreau, L., Keaveney, M., Nevado, J., Zaman, Z., Bryant,
G.O., Struhl, K., and Ptashne, M. (1999). Transcriptional activa-
tion by artificial recruitment in yeast is influenced by promoter
architecture and downstream sequences. Proc. Natl. Acad. Sci.
USA 96, 2668–2673.
26. Keaveney, M., and Struhl, K. (1998). Activator-mediated recruit-
ment of the RNA polymerase II machinery is the predominant
mechanism for transcriptional activation in yeast. Mol. Cell 1,
917–924.
27. Balciunas, D., Hallberg, M., Bjorklund, S., and Ronne, H. (2003).
Functional interactions within yeast mediator and evidence of
